Rankings
▼
Calendar
RGEN Q4 2025 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q4 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$198M
+18.1% YoY
Gross Profit
$93M
47.2% margin
Operating Income
$19M
9.4% margin
Net Income
$13M
6.7% margin
EPS (Diluted)
$0.23
QoQ Revenue Growth
+4.8%
Cash Flow
Operating Cash Flow
$26M
Free Cash Flow
$17M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$2.9B
Total Liabilities
$844M
Stockholders' Equity
$2.1B
Cash & Equivalents
$566M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$198M
$168M
+18.1%
Gross Profit
$93M
$39M
+140.6%
Operating Income
$19M
-$37M
+150.8%
Net Income
$13M
-$34M
+139.2%
Revenue Segments
Product
$198M
100%
← FY 2025
All Quarters